Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 27, 2023
The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma controlBradley Chipps, Robert S Zeiger, David A Beuther, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 23, 2022
The Asthma Impairment and Risk Questionnaire (AIRQ) Control Level Predicts Future Risk of Asthma ExacerbationsDavid A Beuther, Kevin R Murphy, Robert S Zeiger, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 18, 2024
Assessing meaningful change in the Asthma Impairment and Risk QuestionnaireWilliam McCann, Kevin R Murphy, Robert S Zeiger, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 5, 2022
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recallBradley E Chipps, Kevin R Murphy, Robert A Wise, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2026
Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severitiesWilliam A McCann, Bradley E Chipps, David A Beuther, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 30, 2024
Pediatric Asthma Impairment and Risk Questionnaire: Rationale and development of a composite control toolMiguel J Lanz, Bradley E Chipps, Robert S Zeiger, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 1, 2022
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North AmericaJennifer K Quint, Sofie Arnetorp, Janwillem W H Kocks, et al.The Journal of Allergy and Clinical Immunology. in Practice|May 5, 2024
Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction AbilityKevin R Murphy, David A Beuther, Bradley E Chipps, et al.Journal of Asthma and Allergy|January 13, 2023
Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment AdherenceJoan Reibman, Bradley E Chipps, Robert S Zeiger, et al.Therapeutic Advances in Respiratory Disease|October 18, 2025
What is the Asthma Impairment and Risk Questionnaire and how can it help patients with asthma? A plain language summary of publicationsMaureen George, Bradley E Chipps, David A Beuther, et al.Pageof 3